CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+20.99%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$776M
AUM Growth
+$776M
(+6.6%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
74.59%
Holding
29
New
3
Increased
14
Reduced
5
Closed
5
Top Buys
| 1 |
ANI Pharmaceuticals
ANIP
|
$30.5M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$18.5M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$13.9M |
| 4 |
Travere Therapeutics
TVTX
|
$12.4M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$12.3M |
Top Sells
| 1 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$47.9M |
| 2 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$44.6M |
| 3 |
HMSY
HMS Holdings Corp.
HMSY
|
$17.4M |
| 4 |
RLYP
RELYPSA INC COM
RLYP
|
$13.9M |
| 5 |
Option Care Health
OPCH
|
$13.8M |
Sector Composition
| 1 | Healthcare | 71.6% |
| 2 | Industrials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Enanta Pharmaceuticals
ENTA
$180M
| $86.2M | 11.11% | 1,696,147 +97,038 | +6% | +$4.93M |
|
2
United Therapeutics
UTHR
$13.8B
| $85.5M | 11.01% | 660,186 -101,576 | -13% | -$13.2M |
|
|
CSII
3
DELISTED
Cardiovascular Systems, Inc.
CSII
| $64.2M | 8.27% | 2,135,200 +192,146 | +10% | +$5.78M |
|
|
4
ANI Pharmaceuticals
ANIP
$2.03B
| $61.5M | 7.92% | 1,090,067 +540,240 | +98% | +$30.5M |
|
|
AKRX
5
DELISTED
Akorn, Inc.
AKRX
| $60.9M | 7.85% | 1,683,485 +510,000 | +43% | +$18.5M |
|
|
INSY
6
DELISTED
Insys Therapeutics, Inc.
INSY
| $52.9M | 6.81% | 1,254,247 +134,330 | +12% | +$5.66M |
|
|
ANAC
7
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $47.4M | 6.11% | 1,469,690 +431,137 | +42% | +$13.9M |
|
8
AbbVie
ABBV
$372B
| $45M | 5.8% | 687,900 +108,800 | +19% | +$7.12M |
|
9
Orthofix Medical
OFIX
$592M
| $43.2M | 5.56% | 1,436,495 | – | – |
|
|
PTX
10
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $32.2M | 4.15% | 3,427,789 -15,348 | -0.4% | -$144K |
|
|
11
Travere Therapeutics
TVTX
$1.56B
| $31.2M | 4.02% | 2,551,535 +1,012,076 | +66% | +$12.4M |
|
|
HPTX
12
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $30M | 3.87% | 1,251,353 -11,681 | -0.9% | -$280K |
|
|
OSIR
13
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $26.8M | 3.45% | 1,674,561 +95,000 | +6% | +$1.52M |
|
|
TVTY
14
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $26.2M | 3.37% | 1,316,493 +618,303 | +89% | +$12.3M |
|
|
DSCI
15
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $15.2M | 1.96% | 1,632,627 +112,223 | +7% | +$1.04M |
|
16
ADMA Biologics
ADMA
$4.12B
| $9.8M | 1.26% | 877,407 +100,544 | +13% | +$1.12M |
|
17
HealthStream
HSTM
$832M
| $9.46M | 1.22% | 321,026 +147,193 | +85% | +$4.34M |
|
18
Protalix BioTherapeutics
PLX
$124M
| $9.34M | 1.2% | 5,077,338 +50,000 | +1% | +$92K |
|
|
EVDY
19
DELISTED
Everyday Health, Inc.
EVDY
| $9.34M | 1.2% | +633,150 | New | +$9.34M |
|
|
20
Option Care Health
OPCH
$4.65B
| $8.23M | 1.06% | 1,177,145 -1,976,807 | -63% | -$13.8M |
|
21
Vericel Corp
VCEL
$1.83B
| $7.15M | 0.92% | 2,352,940 | – | – |
|
|
HMSY
22
DELISTED
HMS Holdings Corp.
HMSY
| $6.33M | 0.81% | 299,246 -823,880 | -73% | -$17.4M |
|
23
Lineage Cell Therapeutics
LCTX
$267M
| $5.98M | 0.77% | +1,602,550 | New | +$5.98M |
|
|
MSLI
24
DELISTED
Merus Labs International Inc.
MSLI
| $2.25M | 0.29% | +1,360,214 | New | +$2.25M |
|
|
TARO
25
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| – | – | -311,234 | Closed | -$47.9M |
|